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 Abstract  
Background:  Reduced cortical thickness is a candidate biological marker of depression, 
although findings are inconsistent.  This could reflect analytic heterogeneity, such as use of 
region-wise cortical thickness based on the Freesurfer Desikan-Killiany (DK) atlas or surface-
based morphometry (SBM).  The Freesurfer Destrieux (DS) atlas (more, smaller regions) has not 
been utilized in depression studies.  This could also reflect differential gender and age effects.      
Methods:   Cortical thickness was collected from 170 currently depressed adults and 52 never-
depressed adults. Visually inspected and approved Freesurfer-generated surfaces were used to 
extract cortical thickness estimates according to the DK atlas (68 regions) and DS atlas (148 
regions) for region-wise analysis (216 total regions) and for surface-based morphometry (SBM).   
Results:   Overall, except for small effects in a few regions, the two region-wise approaches 
generally failed to discriminate depressed adults from non-depressed adults or current episode 
severity.  Differential effects by age and gender were also rare and small in magnitude.  Using 
SBM, depressed adults showed a significantly thicker cluster in the left supramarginal gyrus than 
non-depressed adults (p = 0.047) but there was no associations with current episode severity.  
Conclusions: Three analytic approaches (i.e., DK atlas, DS atlas, and SBM) converge on the 
notion that cortical thickness is a relatively weak discriminator of current depression status.  
Differential age and gender effects do not appear to represent key moderators. Robust 
associations with demographic factors will likely hinder translation of cortical thickness into a 
clinically-useful biomarker.        
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Introduction 
Cortical thickness, a component of gray matter volume and index of cell density and 
health in the cerebral cortex (Rajkowska et al. 1999), has been reported to be reduced in adults 
with a lifetime history of major depressive disorder (MDD+) relative to adults without a lifetime 
history of major depressive disorder (MDD-; Colloby, et al., 2011; Jarnum, et al., 2011; 
Koolschijn, et al., 2010; Li, et al., 2014; Na, et al., 2016; Schmaal, et al., 2016; Truong, et al., 
2013; Tu, et al., 2012; van Eijndhoven, et al., 2013; Wagner, et al., 2012). In addition to helping 
distinguish subjects with or without MDD for screening or diagnostic purposes, cortical 
thickness may also represent an etiological factor.  For instance, two potent risk factors for MDD 
-- a history of MDD in first-degree relatives (Ozalay, et al., 2016; Papmeyer, et al., 2015; 
Peterson and Weissman, 2011) and heightened trait negative affect (Holmes, et al., 2016) -- have 
also been associated with reduced cortical thickness in certain regions.  In addition, reduced 
cortical thickness was found to precede incidence of depression in a sample of 10-15 year-olds 
(Foland-Ross, et al., 2015) and in a young adult sample (mean age 21 years-old; (Papmeyer, et 
al., 2015). 
Altogether, cortical thickness could represent an important tool for understanding 
etiology of depression, inferring latent risk for depression, and guiding clinical care (e.g., risk 
screening, treatment planning, etc.).  Results, however, have been somewhat inconsistent across 
studies.  Depression has not been linked to reduced cortical thickness in any one particular 
region; rather, each report implicates one or a few frontal, temporal, parietal, and occipital areas 
(see Table 1). Yet other studies report cortical thinning in some regions AND cortical thickening 
in other regions (Fallucca, et al., 2011; Peterson, et al., 2009; Tu, et al., 2012).  For example, 
regions found to have cortical thinning in the largest study to date from the ENIGMA workgroup 
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(~1900 adult MDD subjects), such as the medial orbitofrontal cortex (Schmaal, et al., 2016), 
have been previously reported to be thicker in MDD+ compared to MDD- in smaller studies 
(Qiu, et al., 2014).  Furthermore, several other studies reported no difference between MDD+ 
and MDD- in cortical thickness in any region. 
Summarizing the cortical thickness depression literature is difficult in part because of 
non-uniform approaches to quantifying cortical thickness.  As described in Table 1, all studies 
that conducted region-wise analyses, either a priori region of interest (ROIs) or exploratory 
whole-brain analyses, defined regions according to the Desikan-Killiany (DK) atlas (Desikan, et 
al., 2006). The DK atlas is a well-studied atlas and is standard in FreeSurfer 
(http://surfer.nmr.mgh.harvard.edu/), the most utilized software package for analyzing cortical 
thickness data.  To our knowledge, the Freesurfer-based Destrieux (DS) atlas (Destrieux, et al., 
2010), which offers smaller and more regions relative to the DK atlas, has not been utilized to 
study depression. The reason for this absence is unclear, as psychometric properties of the DS 
atlas are comparable to the DK atlas (Iscan et al., 2015).  In any case, ROI analyses assume that 
depression will be associated with abnormalities that adhere to a priori defined regions, which 
may or may not correspond to underlying pathophysiology.  An alternative strategy used by 
many studies in the literature is surface-based morphometry (SBM), which analyzes whole-brain 
cortical thickness data unconstrained by a priori structure.  It is unclear if these approaches 
converge or diverge in understanding the link between depression and cortical thickness.   
The first goal of this study is to compare 170 subjects with current major depressive 
disorder (MDD+) and 52 never-depressed controls on cortical thickness as measured by these 
two ROI approaches (DK and DS) and by SBM.  This is the first report to our knowledge to 
utilize these three analytic approaches, providing opportunity to describe converging vs 
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diverging links with depression across them.  A secondary goal of the current study is to identify 
potential moderators of the link between depression and cortical thickness.  Prior studies in this 
area utilized case-control comparisons that focused on main effects without exploration of 
potential moderators.  In this report, we consider two demographic moderators (age and gender), 
which show profound links to depression in epidemiological studies of depression.  We also 
examine a clinical feature of depression, namely current episode severity, as it may track cortical 
thickness.     
In this study, we leveraged data collected as part of the Establishing Moderators and 
Biosignatures of Antidepressant Response for Clinical Care (EMBARC) project, a multisite 
study of depression and treatment response (Trivedi, et al., 2016). Data was available for 170 
subjects with current major depressive disorder (MDD+) and 52 never-depressed controls 
(MDD-) assessed at one of four university centers in Massachusetts, Michigan, New York, and 
Texas.  The design of EMBARC is well-suited for investigating the link between cortical 
thickness and depression based on relatively large sample size for a clinical imaging study, 
uniform multi-site recording procedures, uniform data processing blind to diagnosis, and 
thorough clinical characterization of participants using both self-report and diagnostic 
interviews.  Importantly, the imaging protocol and analytic steps utilized by EMBARC, 
including manual inspection procedures, have been thoroughly described and investigated 
elsewhere (Iscan, et al., 2015).  As described by Iscan et al. (2015) in a test-retest study of 40 
healthy adults, cortical thickness data that is visually-inspected and manually approved 
demonstrates higher reliability (ICC = 0.77 for DS; ICC = 0.81 for DK) compared to when this is 
skipped (ICC = 0.59 for DS; ICC = 0.62 for DK).  Because visual inspection is burdensome and 
time consuming, many studies are unable to implement this processing step.  To our knowledge, 
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this is the largest study to date that uses identical processing conditions and manual-inspection 
procedures to compare Freesurfer-derived cortical thickness measurements between depressed 
and non-depressed cohorts.   
 
Methods and Materials 
Details about the ongoing EMBARC study, including ascertainment and randomization, 
have been reported elsewhere (Trivedi, et al., 2016; Webb et al., 2016; Delaparte et al., 2017; 
Olvet et al., 2015).  All participants were between the ages of 18 and 65 years-old and provided 
signed consent.  Inclusion criteria for MDD+ subjects were to be in a current depressive episode, 
verified by a semi-structured clinical interview conducted by a trained interviewer, and to have a 
clinically-significant score of at least 14 on the Quick Inventory of Depressive Symptoms 
(QIDS-SR; (Rush, et al., 2003)). MDD+ and MDD- subjects were excluded for current 
pregnancy, lifetime history of psychosis or bipolar disorder, substance dependence within the 
previous 6 months, substance abuse within the past 2 months, or any factor that would obscure 
treatment response in the randomization trial (recent treatment for depression involving other 
medications, somatic treatments, or psychotherapy) or contraindicate use of study medication 
(i.e., risk of interaction with ongoing medication, clinically significant laboratory results, etc.).   
Data Acquisition  
Specific details about scanning, processing, and sequence parameters have been 
published elsewhere (Iscan, et al., 2015). To summarize, T1w images were acquired with 3T 
MRI scanners at each site. An MPRAGE sequence was used at the University of Texas 
Southwestern Medical Center (TX: Philips Achieva, 8-channel (ch) head coil), University of 
Michigan (UM: Philips Ingenia, 15-ch), and Massachusetts General Hospital and Stony Brook 
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University (MGH & SBU: Siemens TrioTim, 12-ch), while an IR-FSPGR sequence was used at 
Columbia University Medical Center (CU: GE Signa HDx, 8-ch).  The following MR parameters 
were consistent across sites: TR (repetition time): 5.9-8.2 ms, TE (echo time): 2.4-4.6 ms, Flip 
Angle: 8-12°, slice thickness: 1 mm, Field of View: 256×256 mm, voxel dimensions: 1 mm 
isotropic, acquisition matrix: 256×256 or 256×243, acceleration factor: 2, and 174-78 sagittal 
slices.  Acquisition times ranged from 4.4 to 5.5 minutes.   
Processing 
Cortical thickness was computed for 34 bilateral Desikan-Killiany (DK) atlas regions (Desikan, 
et al., 2006) and 74 bilateral Destrieux (DS) atlas regions (Destrieux, et al., 2010) using 
FreeSurfer 5.3.0’s standard, automated cortical reconstruction pipeline 
(http://surfer.nmr.mgh.harvard.edu/) on a Linux-based computing cluster. The pipeline’s 
subroutines have been described in previous publications (Iscan, et al., 2015); the processing 
steps include skull-stripping (Segonne, et al., 2004), Talairach transformation, subcortical 
grey/white matter segmentation (Fischl, et al., 2002), intensity normalization (Sled, et al., 1998), 
grey/white matter tessellation, topology correction (Fischl, et al., 2001; Segonne, et al., 2007) 
and intensity gradient based surface deformation to generate grey/white and grey/cerebrospinal 
fluid surface models (Dale, et al., 1999; Fischl, et al., 2001; Segonne, et al., 2007). The resulting 
surface models were then inflated and registered to a spherical surface atlas, allowing 
parcellation of cortical regions of interest (Fischl, et al., 1999a; Fischl, et al., 1999b; Fischl, et 
al., 2004). Finally, regional cortical thicknesses were computed by taking the mean of the white-
pial distance at all vertices within each parcellated region (Fischl and Dale, 2000). The surface 
models (used to calculate cortical thickness) then underwent an empirical, systematic inspection 
process (Iscan, et al., 2015) in which a trained technician carefully inspected 2D sections of the 
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pial and white surface models overlaid on the T1w image for fidelity to visible tissue class 
boundaries. Cases where inaccurate tissue delineation persisted for ≥6 consecutive coronal and 
axial slices were deemed inaccurate and thus disqualified from further analyses. Of 293 eligible 
cases inspected, 222 (76%) passed inspection. All technicians were blinded to subject diagnoses.   
Statistical Analysis 
Region-Wise Analysis: The region-wise cortical thickness estimates from the DS and DK atlases 
were analyzed in R (R Development Core Team, Vienna, Austria. http://www.R-project.org).  
Bivariate associations were described using Pearson correlations.  Group differences (i.e., 
MDD+ vs MDD-) were tested using hierarchical linear models.  First, extraneous factors were 
modeled as covariates in Step 1: age and age
2
 (Salat, et al., 2004; Sowell, et al., 2007), gender 
(Luders, et al., 2006; Savic and Arver, 2014), education (Kim et al., 2015), and recording site 
(Iscan, et al., 2015). Then, group status (MDD+ vs MDD-) was added in Step 2 to determine the 
amount of variance associated with diagnosis over and above Step 1.  Next, the interactions for 
diagnosis by age (Step 3a) and diagnosis by gender (Step 3b) were added to determine the 
amount of variance accounted for over and above Step 2.  Analysis of current depression severity 
(QIDS score) excluded controls, as well as one depressed case for which QIDS score was not 
available (n = 169).   
In all region-wise analyses, the magnitude of effect (i.e., change in r
2 
from Step 1 to Step 
2, change in r
2
 from Step 2 to Step 3a/3b) and p-value level were reported.  Pearson’s r were 
reported for the association between depression severity and cortical thickness in order to 
convey the direction of the association.  When interpreting the results, we also considered the 
number of significant effects relative to number of tests.  We note that r
2
 is easily converted to 
other effect size metrics for comparison with other studies or use in meta-analysis (See 
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Rosenthal, 1994).  
SBM Analysis: All SBM analyses were performed in Freesurfer 5.3.0. The approved cortical 
thickness maps for each subject were first registered to a common spherical atlas (Fischl, et al., 
1999b) and smoothed with a 10mm Gaussian kernel. A general linear model (GLM) was used to 
examine the vertex-wise differences in cortical thickness: (1) between the MDD+ and MDD- 
groups and (2) associated with QIDS score, controlling for age, age
2
, gender, education, and site. 
Right and left hemispheres were examined separately. A Monte Carlo Null-Z simulation cluster 
analysis with 10,000 iterations and cluster-forming threshold of p < 0.001 was used to correct for 
multiple comparisons and is explained in detail elsewhere (Wagner, et al., 2012).  In short, the 
family-wise error significance threshold was set at p < 0.05 and through a combination of 
probability and cluster-size thresholding, cluster-wise probability (CWP) p-values are obtained 
for resulting clusters. This CWP result represents the overall alpha significance level for the 
cluster. The Monte Carlo simulation and clustering is based on the AlphaSim algorithm (Ward, 
2000). 
Results 
Demographics: Table 2 presents the sample characteristics by imaging site.  The sites were 
similar in proportion of MDD+ vs MDD-, course of depression, gender, age, education, QIDS 
score, and total brain volume.  There was a significant site effect for number of discreet episodes 
of depression reported by MDD+ subjects (log10 transformed due to skew; winsorized to 20 as 
maximum due to skew).  Post hoc comparisons revealed that MDD+ subjects at Michigan 
reported more discrete episodes of depression than MDD+ subjects at Columbia (p = 0.006) and 
Harvard (p = 0.04).  The MDD+ subjects did not differ by site in lifetime rates of Panic Disorder, 
Obsessive Compulsive Disorder, Specific Phobia, Social Phobia, Anorexia Nervosa, Bulimia 
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Nervosa, or Any Illicit Substance Use Disorder (a composite category that excluded nicotine and 
alcohol).  MDD+ subjects at Michigan were more likely to meet criteria for Post-traumatic Stress 
Disorder and Alcohol Use Disorder than MDD+ subjects at other sites. 
 
Freesurfer Desikan-Killiany Atlas: Table 2 presents the proportion of variance in cortical 
thickness accounted for by age, age
2
, gender, education, and site.  On average, these factors 
accounted for approximately 23% of individual differences in left hemisphere and right 
hemisphere cortical thickness.  The incremental main effect of depression (Model 2) was weakly 
related to cortical thickness (all p-values > 0.05).  The interaction between depression and age 
(Model 3a; while controlling for main effects) was weakly related to cortical thickness (all p-
values > 0.05).  The interaction between depression and gender (Model 3b; while controlling for 
main effects) identified 2 significant effects at p < 0.01 (2.94% of 68 interactions; see 
Supplemental Figure 1 and 2).  The largest effect was the left cuneus, which accounted for 
2.8% of variance in that region over and above covariates and main effect of depression.  In 
both cases, greater cortical thickness was observed in depressed males compared to 
depressed females and less cortical thickness was observed in non-depressed males 
compared to non-depressed females. 
 Among depressed cases only, covariates accounted for approximately 22% of individual 
differences in left hemisphere and right hemisphere cortical thickness on average (see 
supplemental table 1).  Current depression severity (Model 2) was negatively associated with 
cortical thickness in the right middle temporal gyrus at p < 0.01 (1.47% of 68 tests).  This effect 
accounted for 4.28% of variance in that region over and above covariates.  The interaction 
between depression severity and age (Model 3a) was significant in the left bankssts at p < 0.01 
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(1.47% of 68 interactions), which accounted for 3.53% of variance in that region over covariates 
and main effect of depression severity (see Supplemental Figure 3).  As shown in 
Supplemental Figure 3, higher QIDS scores were associated less cortical thickness in this 
region at older ages.  The interaction between depression severity and gender (Model 3b) was 
weakly related to cortical thickness (all p-values > 0.01). 
Freesurfer Destrieux Atlas: Table 3 presents the proportion of variance in cortical 
thickness accounted for by age, age
2
, gender, and site.  On average, these factors accounted for 
approximately 19% (left hemisphere) and 20% (right hemisphere) of individual differences in 
cortical thickness.  The incremental main effect of depression (Model 2) was weakly related to 
cortical thickness (all p-values > 0.01). One interaction between depression and age (Model 3a) 
identified the left middle occipital gyrus as significant at p < 0.01 (0.06% of 148 interactions; see 
Supplemental Figure 4).  In this region, cortical thinning with age appears attenuated in 
currently depressed compared to never depressed adults.  The interaction between depression 
and gender (Model 3b) identified 4 significant effects at p < 0.01 (2.7% of 148 interactions; (see 
Supplemental Figure 5 – Figure 8).  The largest magnitude of effect was in the right temporal 
transverse sulcus, which accounted for 3.7% of variance in cortical thickness in that region.  As 
shown in Supplemental Figure 8, never-depressed males exhibit less cortical thickness in 
this region than never-depressed females, whereas similar cortical thickness was observed 
between currently depressed males and females.  
Among depressed cases only, covariates accounted for approximately 18% (left 
hemisphere) and 19% (right hemisphere) of individual differences in cortical thickness.  Current 
depression severity (Model 2) was negatively associated with cortical thickness in 4 regions at p 
< 0.01, the strongest of which was in the right occipital anterior sulcus (5.29% of variance; 2.7% 
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of 148 interactions).  Depression severity interacted with age (Model 3a) in one region at p < 
0.01, the left anterior occipital sulcus and accounted for 4.41% of variance in that region (see 
Supplemental Figure 9).  As shown, higher QIDS scores was associated with less cortical 
thickness in this region at older ages.  The interaction between depression severity and gender 
(Model 3b) was weakly related to cortical thickness (all p-values > 0.01).   
 Surface-Based Morphometry: After multiple comparisons correction, vertex-wise whole-
brain comparisons of MDD+ to MDD- revealed that the MDD+ group had thicker left 
supramarginal gyri than the MDD- group, with a cluster size of 177.86 mm
2 
and a cluster-wise, 
corrected p-value of 0.047 (see Figure 1). This region is denoted as supramarginal in Freesurfer, 
although the cluster extends into the inferior parietal region.  The analysis of current depression 
severity (QIDS score) in the MDD+ group did not identify any clusters after multiple 
comparisons correction. 
  
Discussion 
In this report, we examined the association between cortical thickness and major 
depressive disorder using data from 170 currently-depressed adults and 52 never-depressed 
adults collected as part of a multi-site study.  To our knowledge, this is the first depression study 
to examine three strategies for assessing cortical thickness and is the largest to employ a 
previously validated, slice-wise visual-inspection method on every participant’s cortical 
thickness data (Iscan, et al., 2015). This essential step is often impractical due to the burden of 
staff time required, but improves data quality (i.e., test-retest reliability) relative to fully-
automated processing steps without manual approval (Iscan, et al., 2015).  Moreover, this is also 
the first study to our knowledge to compare depressed and non-depressed adults using regions 
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defined by the DS atlas.  Compared to the DK atlas, the DS atlas offers more, smaller targets, 
and has also demonstrated strong test-retest reliability (Iscan, et al., 2015).   Finally, this is the 
first cortical thickness depression study to explore differential age and gender effects.   
Essentially, our main result is that currently-depressed adults and never-depressed adults 
exhibited comparable levels of cortical thickness.  The DK atlas--which is notable for fewer, 
larger regions and use in all prior a priori, region-based studies of depression--did not 
discriminate subjects with depression from never-depressed adults in any region.  A few effects 
were observed with the smaller, more regions defined by the DS atlas; however, effect sizes were 
small and consistent with the false positive rate.  The third analytic method, surface-based 
morphometry, identified a small area of cortical thickening in the left supramarginal gyrus that 
survived correction for multiple comparisons.  Thus, if present in depressed adults, reduced 
cortical thickness likely reflects a small effect size in affected regions.  A similar conclusion was 
reached in prior reports that utilized the DK atlas to measure cortical thickness (Phillips, et al., 
2015; Schmaal, et al., 2016).  The currently study extends this conclusion to cortical thickness 
analyzed using the SBM approach and the DS atlas.     
That we identified the left supramarginal gyrus as thicker in depression is intriguing 
because it replicates two previous SBM studies of depression (Qiu, et al., 2014; Yang, et al., 
2015) and contradicts a third (Ozalay, et al., 2016).  It is worth noting that the DS and DK atlases 
each cover this area.  Unfortunately, we can only speculate as to why SPM but not region-wise 
analysis identify this region as tracking increased cortical thickness in depression.  The 
inconsistency of results across methods may reflect that atlases define regions, according to 
structural boundaries that do not necessarily correspond to indicators of cortical pathophysiology 
in depression.  That is, SPM may be better for detecting cortical thickness effects that do not fit 
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neatly into predefined regions.  Of note, previous ROI studies using the DK atlas have not 
always reported results for regions corresponding to the supramarginal gyrus.  This “missing 
data” in the literature significantly hinders efforts to integrate findings in either a qualitative 
review of the literature or a meta-analysis.  Thus, focused hypothesis-testing designs keep the 
false positive rate low, but also hinder efforts to integrate findings across studies.   
Depression is a heterogeneous phenotype subject to wide intra- and inter-variability in 
course, symptoms, response to treatment, and etiology.  This heterogeneity may obscure the link 
between depression and cortical thickness, at least to the extent that only specific features of 
depression track cortical thickness.  We pursued this question via exploratory age and gender 
interactions with depression. Overall, these effects provided no more than a few small magnitude 
effects, and it remains unclear which features of current depression best track cortical thickness.  
It is important to emphasize that our study examined a cohort that was relatively homogenous for 
chronic depression, which includes many who reported a single-episode of depression that 
continued unremitted or with only partial remission for many years, as well as many who report 
recurrent depression characterized by full inter-episode recovery.  Therefore, we cannot rule out 
the possibility that cortical thickness better tracks depression in other kinds of depressed cohorts.  
In addition, more powerful within-subject designs may yet reveal that depression is associated 
with differential rate of change in cortical thickness across adulthood. 
  That cortical thickness appears no more than weakly related to current depression 
should inform the design and implementation of future studies.  Strategies to combine datasets or 
results (e.g., meta-analysis), such as that employed by ENIGMA (Schmaal, et al., 2016), may be 
more effective than single studies in confirming the presence of subtle thinning in specific 
regions. Second, cortical thickness appears highly sensitive to several extraneous sources of 
Page 15 of 56
John Wiley & Sons, Inc.
Human Brain Mapping
This article is protected by copyright. All rights reserved.
A
cc
ep
te
d 
A
rt
ic
le
Perlman 16 
 
variances. In this study, the combined effects of age, age
2
, sex, education, and site differences 
accounted for nearly a fifth of the total individual differences in cortical thickness. This is much 
larger than estimates of the effect of depression on cortical thickness.  Thus, the strategies by 
which studies adjust for these factors may have a significant impact on the results. Future 
research may benefit from establishing cortical thickness normative data to enhance 
compatibility between recording sites and studies and optimally control for these factors.  
There are a number of limitations to this study. First, although we examined a large 
sample of depressed subjects relative to many other studies, larger samples may be needed to 
detect subtle associations and identify moderators.  In particular, inclusion of fewer non-
depressed adults than depressed adults necessarily lowered statistical power to detect group 
differences.  However, larger samples would not be expected to yield larger magnitude 
associations (Phillips, et al., 2015; Schmaal, et al., 2016).  Second, site differences may have 
masked an association between cortical thickness and depression.  However, considerable effort 
was made to create and apply uniform procedures for sample ascertainment and recording; sites 
were matched on proportion of cases and controls, gender, mean age, and current depressive 
severity; and site differences were statistically controlled for in our analyses in order to minimize 
impact on results. Third, we were unable to conduct exploratory analyses of all candidate 
moderators of the association between MDD and cortical thickness. This is because the sample 
was relatively homogenous for long-duration, chronic depression.  Future studies of moderators 
may benefit from examining a more heterogeneous depressed cohort, including remitted cases 
and recent first-onset cases.   The list of potential moderators of the link between cortical 
thickness and MDD is lengthy, as it includes any trait or disease previously correlated with 
cortical thickness. This list includes health-related phenotypes, such as diabetes (Ajilore, et al., 
Page 16 of 56
John Wiley & Sons, Inc.
Human Brain Mapping
This article is protected by copyright. All rights reserved.
A
cc
ep
te
d 
A
rt
ic
le
Perlman 17 
 
2010; Franc, et al., 2011) and obesity (Kim, et al., 2015); as well as individual difference traits, 
such as cognitive ability (Burzynska, et al., 2012; Klein, et al., 2014), religiosity (Miller, et al., 
2014), meditation experience (Lazar, et al., 2005), and negative affect (Holmes, et al., 2016).  
Along these lines, diagnostic comorbidity is a potential moderator of the link between cortical 
thickness and depression.  While comorbidity is common in clinical samples of depressed adults, 
the current study was not designed to parse unique effects of comorbidity patterns on cortical 
thickness. 
In summary, to our knowledge, this was the second largest study of cortical thickness in 
depression, the first to examine three separate analytic methods and differential age and gender 
effects, and the first large study to employ strict quality control procedures during data 
processing.  Although previous reports describe robust associations between major depressive 
disorder and reduced cortical thickness, the current study finds such an association to be 
relatively weak at best.  Larger sample sizes and more comprehensive searches for moderators 
may yield more robust effects.
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Table 1   Selected Publications Investigating Cortical Thickness in MDD 
Author Year Journal Subjects Method Relevant CT Findings in MDDs compared to HCs 
Koolschijn 2010 
Eur 
Neuropsychopharmacol 
28 elderly 
MDDs, 38 HCs 
SBM No findings. 
Colloby 2011 J Affect Disord 
38 late-life 
MDDs, 30 HCs 
Freesurfer 
Region-wise: 
DK 
No findings. 
Han 2014 J Affect Disord 
20 1st ep. 
MDDs, 22 HCs 
 Freesurfer 
SBM 
No findings. 
Lan 2014 Bipolar Disord 
56 MDDs, 54 
HCs 
 Freesurfer 
SBM 
No findings. 
Phillips 2015 
Int J 
Neuropsychopharmacol 
26 treatment-
resistant 
MDDs, 28 HCs 
Freesurfer 
Region-wise: 
DK 
No findings. 
Peterson 2009 Proc Natl Acad Sci USA 
66 HR children, 
65 LR children  
 Freesurfer 
SBM 
 right lateral cerebral hemisphere in HRs vs LRs. 
Peterson & 
Weissman 
2011 Annu Rev Med 
66 HR children, 
65 LR children  
 Freesurfer 
SBM 
 cortical mantle over the lateral convexity of the right 
hemisphere & the medial surface of the left hemisphere in 
HRs vs LRs. 
Tu 2012 Psychiatry Res 
36 MDDs, 36 
HCs 
 Freesurfer 
SBM 
 left anterior insula & left lOFC.  left lOFC, par 
opercularis, and caudal & rostral middle frontal gyrus in 
MDDs with more episodes vs MDDs with less episodes. 
Wagner 2012 J Psychiatr Res 
15 HR for 
suicide MDDs, 
15 not-HR for 
suicide MDDs , 
30 HCs 
 Freesurfer 
SBM 
 left dlPFC, left vlPFC & dACC in HR MDDs vs non-HR MDDs.  
Truong 2013 Psychiatry Res 
49 MDDs, 64 
HCs 
SBM 
 left dlPFC.  dlPFC, pre- and postcentral gyrus, & lingual 
gyrus in early onset MDDs vs HCs.  
Li 2014 J Affect Disord 
24 MDDs, 24 
HCs 
 Freesurfer 
SBM 
 dACC in MDDs vs HCs. 
Holmes 2016 J Neurosci 
1050 young 
adults without 
MDD 
 Freesurfer 
SBM 
 left sgACC & left rACC associated with heightened negative 
affect. 
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Holmes 2016 J Neurosci 
1050 young 
adults 
without 
MDD 
 
Freesurfer 
SBM 
 left sgACC & left rACC associated with heightened 
negative affect. 
Liu 2015 Depress Anxiety 
30 med-
naïve 
MDDs, 41 
HCs 
 
Freesurfer 
SBM 
 left lOFC in MDDs vs HCs. 
Foland-
Ross 
2015 J Abnorm Psychol 
28 
adolescent 
daughters 
of mothers 
with MDD 
(HRs), 36 
adolescent 
LRs 
 
Freesurfer 
SBM & 
Region-
wise: DK 
 right fusiform gyrus in HRs vs LRs. 
Na 2016 Sci Rep 
65 
recurrent 
MDDs, 65 
HCs 
Freesurfer 
SBM 
right mOFC, lingual gyrus, lateral occipital & left 
lOFC, pars triangularis, lingual gyrus in MDDs vs HCs. 
Schmaal 2016 Mol Psychiatry 
1902 adult 
MDDs, 
7658 HC; 
213 
adolescent 
MDDs, 294 
HCs 
Freesurfer 
Region-
wise: DK 
mOFC, fusiform gyrus, rACC, PCC, insula, & temporal 
lobe in adult MDDs vs HCs. left middle temporal 
gyrus, right inferior temporal gyrus, & right cACC in 
adult MDDs vs HCs. No findings in adolescent MDDs vs 
adolescent HCs. 
Jaworska 2014 Biomed Res Int 
36 MDDs, 
18 HCs 
Freesurfer 
Region-
wise: DK 
 frontal pole in MDDs vs HCs. 
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Qiu 2014 Transl Psychiatry 
46 1st ep, 
med-naïve 
MDDs, 46 
HCs 
 
Freesurfer 
SBM 
 right mOFC, pars opercularis, rostral middle frontal 
gyrus, & supramarginal gyrus in MDDs vs HCs. 
Reynolds 2014 BMC Psychiatry 
30 
adolescent 
MDDs, 16 
adolescent 
HCs 
Freesurfer 
Region-
wise: DK 
 right & left rostral middle frontal gyrus and left 
cACC in adolescent MDDs vs adolescent HCs. 
Yang 2015 Psychiatry Res 
27 1st-ep 
MDDs, 27 
HCs 
 
Freesurfer 
SBM 
 right OFC & left inferior parietal gyrus in MDDs vs 
HCs. 
Szymkowicz 2016 Int J Geriatr Psychiatry 
43 elderly 
MDDs 
 
Freesurfer 
SBM & 
Region-
wise: DK 
 right isthmus cingulate & left precuneus associated 
with depressive symptom severity. 
Fonseka 2016 BMC Psychiatry 
13 young 
adult 
MDDs, 14 
HCs 
Freesurfer 
Region-
wise: DK 
 left pars opercularis in MDDs vs HCs. 
van 
Eijndhoven 
2013 Am J Psychiatry 
20 med-
naïve, 1st 
ep. MDDs, 
31 HCs 
 
Freesurfer 
SBM 
 left mOFC.  left & right temporal pole, left cACC & 
left PCC in MDDs vs HCs. 
Fallucca 2011 Arch Gen Psychiatry 
24 
pediatric 
MDDs, 24 
pediatric 
OCDs, 30 
HCs 
 
Freesurfer 
SBM 
 right pericalcarine, right postcentral, right superior 
parietal gyrus, & left supramarginal gyrus.   left & 
right temporal pole in pediatric MDDs vs pediatric HCs. 
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Foland-
Ross 
2015 Int J Dev Neurosci 
33 
adolescents 
without 
MDD 
Freesurfer 
Region-
wise: DK 
CT correctly predicted onset of MDD (accuracy of 70%) 
in adolescents. Right mOFC, right precentral, left ACC, 
& bilateral insula contributed most strongly. 
Papmeyer 2015 Biol Psychiatry 
111 HR 
young 
adults, 93 
HCs, 20 HRs 
developed 
MDD 
Freesurfer 
Region-
wise: DK 
 right parahippocampal & right fusiform gyrus in HRs 
vs HCs.  parahippocampi &  left inferior frontal 
gyrus in MDDs vs HRs who did not develop MDD.  left 
inferior frontal & left precentral gyrus in MDDs vs HRs 
who did not develop MDD & vs HCs 
Ozalay 2016 Psychiatry Res 
24 female 
MDDs & 
daughters 
(HRs), 24 
HC females 
& 
daughters 
(LRs) 
Freesurfer 
SBM 
right supramarginal gyrus, caudal middle frontal 
gyrus, & lOFC in female MDDs vs female HCs.. left 
superior temporal gyrus in female MDDs vs female HCs. 
right inferior parietal gyrus, right superior frontal 
gyrus, & left ventral insula, left superior posterior 
temporal, temporal pole, fusiform gyrus, & dACC in 
HRs vs LRs. right precentral gyrus in HRs vs LRs. 
CT: Cortical Thickness | SBM: Surface-Based Morphometry | MDDs: Persons with major depressive disorder | HCs: Healthy Controls | HRs: 
Persons at high-risk for MDD | LRs: Persons at low-risk for MDD | DK: Desikan-Killiany Atlas | DS: Destrieux atlas| lOFC, mOFC, OFC: lateral-, 
medial-, orbitofrontal cortex | dlPFC, vlPFC: dorsolateral-, ventrolateral prefrontal cortex |  dACC, cACC, sgACC, rACC: dorsal-, caudal-, 
subgenual-, rostral anterior cingulate cortex | PCC: posterior cingulate cortex  
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Table 2. Descriptive Statistics by Imaging Site 
  Columbia  Harvard  Michigan  UTSW  Statistic 
  MDD+ MDD-  MDD+ MDD-  MDD+ MDD-  MDD+ MDD-   
  n n  n n  n n  n n   
Group  44 12  34 17  33 9  59 14  χsite(3) = 3.74, p 
= 0.29 
                  
Course               χsite(3) = 6.18, p 
= 0.10 
  Recurrent  36 --  26 --  32 --  51 --   
  Single Episode  8 --  8 --  1 --  8 --   
               
Gender              χsite(3) = 2.59, p 
= 0.47 
    M  21 4  16 8  11 3  20 8   
    F  23 8  18 9  22 6  39 6   
               
Education Level 
    
             χsite(3) = 5.78, p 
= 0.12 
>16 years  26 7  15 9  14 5  21 8   
< 16 years  16 5  19 8  19 4  38 6   
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Lifetime  
Psychopathology 
              
   Panic Disorder  9 0  6 0  5 0  7 0  χsite(3) = 1.40, p 
= 0.71 
   OCD  0 0  2 0  0 0  4 0  χsite(3) = 5.20, p 
= 0.16 
   Specific Phobia  8 0  6 0  11 0  7 0  χsite(3) = 6.46, p 
= 0.09 
   Social Phobia  2 0  0 0  4 0  9 0  χsite(3) = 4.99, p 
= 0.17 
   PTSD  6 0  1 0  11 0  9 0  χsite(3) = 11.97, p 
= 0.01 
   Anorexia  1 0  0 0  0 0  1 0  χsite(3) = 1.39, p 
= 0.71 
  Bulimia  0 1  3 0  0 0  1 0  χsite(3) = 5.51, p 
= 0.14 
  Alcohol Use    
Disorder 
 6 0  2 1  10 0  15 0  χsite(3) = 8.78, p 
= 0.03 
  Illicit Use Disorder  5 1  3 0  6 0  12 0  χsite(3) = 3.00, p 
= 0.39 
  Mean 
(SD) 
Range 
Mean 
(SD) 
Range 
 Mean 
(SD) 
Range 
Mean 
(SD) 
Range 
 Mean 
(SD) 
Range 
Mean 
(SD) 
Range 
 Mean 
(SD) 
Range 
Mean 
(SD) 
Range 
  
               
Number of 
Episodes
^&
 
 5.32 
(6.23) 
1-20 
--  6.18 
(6.31) 
1-20 
--  9.36 
(6.74) 
1-20 
--  9.14 
(7.60) 
1-20 
--  Fsite(3,166) = 
2.85, p = 0.04, 
Post Hoc: M > 
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Note: ^ = For ANOVA, data was log10 +1 transformed due to positive skew; & = Data was windsored to 20 for reporting descriptive 
statistics.    * = 10
5
 and millimeters
3 
2 participants at Columbia declined to report education. 
.
C, M > H 
               
Age   34.45 
(10.52) 
18-61 
36.92 
(13.23) 
18-64 
 35.44 
(14.69) 
18-60 
39.24 
(18.46) 
18-65 
 34.36 
(13.11) 
18-58 
43.78 
(15.19) 
23-62 
 41.37 
(11.40) 
19-63 
32.71 
(11.75) 
20-57 
 Fsite(3,214) = 
0.37, p = 0.77, 
FDX(1,214) = 
0.69, p = 0.41, 
Fint(3,214) = 
3.30, p = 0.02 
               
Total Brain 
Volume* 
 1.15 
(0.14) 
0.85-
1.54 
1.14 
(0.13) 
0.99-
1.44) 
 1.12 
(0.10) 
0.91-
1.41 
1.12 
(0.11) 
0.87-
1.29 
 1.12 
(0.12) 
0.92-
1.43 
1.09 
(0.15) 
0.90-
1.28 
 1.11 
 (0.11) 
0.85-
1.39 
1.19 
(0.16) 
0.97-
1.54 
 Fsite (3,214) = 
1.23, p = 0.30, 
FDX(1,214) = 
0.24, p = 0.62, 
Fint(3,214) = 
1.82, p = 0.14 
               
Quick Inventory of 
Depression 
Symptoms 
 19.00 
(2.98) 
14-24 
1.50 
(1.13) 
0-4 
 17.65 
(2.89) 
14-27 
1.12 
(1.05) 
0-3 
 18.67 
(3.27) 
14-27 
2.22 
(1.99) 
0-6 
 17.28 
(2.43) 
14-24 
1.14 
(1.29) 
0-4 
 Fsite(3, 213) = 
2.11, p = 0.10, 
FDX(1,213) = 
1,561, p < 0.01, 
Fint(3,213) = 
0.51, p = 0.68 
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Table 3. Effect of Depression on Cortical Thickness derived from DK atlas 
 
MDD+ MDD- 
 
Model 1: 
Covariates only 
 
Model 2: 
Covariates 
+ MDD 
 
Model 3a: 
Model 2 + 
MDD x Age 
 Model 3b: 
Model 2 + 
MDD x Gender 
 
L R L R 
 
L R  L R  L R  L R 
Region adapted from atlas 
Mean SD Mean SD Mean SD Mean SD 
 
r
2 
%  ∆ r
2
 % 
 
∆ r
2
 % 
 
∆ r
2
 % 
Bankssts 2.51 0.17 2.60 0.18 2.52 0.18 2.59 0.18 
 
21.06 21.47  0.04 0.02  0.02 0.00  0.27 0.25 
Caudal Anterior Cing ulate 2.58 0.26 2.54 0.21 2.64 0.25 2.57 0.29 
 
9.56 10.26  0.29 0.22  0.52 0.07  0.04 1.06 
Caudal Middle Frontal 2.54 0.17 2.54 0.16 2.55 0.15 2.52 0.16  25.46 24.2 
 
0.02 0.35 
 
0.00 0.06 
 
0.03 0.80 
Cuneus 1.75 0.15 1.78 0.15 1.77 0.12 1.82 0.14 
 
21.43 30.36  0.04 0.09  0.20 0.00  2.83** 1.15 
Entorhinal 3.37 0.35 3.47 0.40 3.33 0.30 3.40 0.37  8.36 19.59  0.63 0.75  0.35 0.05  0.86 0.11 
Frontal Pole 2.82 0.30 2.78 0.30 2.83 0.33 2.78 0.28 
 
22.25 12.27  0.15 0.02  0.54 0.14  1.53* 0.74 
Fusiform 2.72 0.16 2.70 0.18 2.72 0.19 2.72 0.16  28.2 26.23  0.03 0.03  0.35 0.29  0.04 0.04 
Inferior Parietal 2.45 0.14 2.47 0.13 2.45 0.15 2.47 0.14  17.67 24.25 
 
0.03 0.03 
 
0.22 0.08 
 
0.44 1.18 
Inferior Temporal 2.81 0.17 2.81 0.18 2.82 0.16 2.86 0.16 
 
17.46 16.87  0.01 0.77  0.24 0.01  0.78 0.12 
Insula 3.03 0.18 2.99 0.19 3.02 0.17 3.04 0.16 
 
22.51 27.01  0.22 0.51  0.28 0.14  0.53 0.27 
Isthmus Cingulate 2.54 0.24 2.47 0.22 2.51 0.21 2.43 0.23  17.86 15.71 
 
0.33 0.23 
 
0.01 0.03 
 
0.15 0.41 
Lateral Occipital 2.14 0.14 2.20 0.15 2.13 0.13 2.20 0.15 
 
11.48 8.38  0.24 0.07  0.20 0.03  0.40 0.47 
Lateral Orbitofrontal 2.68 0.18 2.65 0.19 2.68 0.18 2.65 0.22 
 
25.91 25.97  0.02 0.01  0.05 0.63  0.20 0.35 
Lingual 1.96 0.16 2.01 0.16 1.98 0.15 2.03 0.12  37.13 34.01 
 
0.01 0.00 
 
0.00 0.07 
 
1.41* 2.43** 
Medial Orbitofrontal 2.43 0.19 2.42 0.21 2.38 0.18 2.45 0.24 
 
26.44 30.89  0.92 0.44  0.52 0.07  1.27 1.75* 
Middle Temporal 2.88 0.16 2.91 0.17 2.89 0.16 2.93 0.17 
 
28.67 24.97  0.10 0.49  0.01 0.32  1.17 1.31 
Paracentral 2.30 0.17 2.32 0.19 2.34 0.14 2.32 0.17  26.02 33.72 
 
0.22 0.29 
 
0.07 0.32 
 
0.12 0.16 
Parahippocampal 2.77 0.36 2.70 0.30 2.75 0.34 2.70 0.25 
 
10.79 17.52  0.22 0.28  0.05 0.07  1.17 0.62 
Pars Opercularis 2.58 0.16 2.59 0.18 2.59 0.17 2.61 0.19 
 
31.82 25.11  0.15 0.21  0.16 0.33  0.32 0.52 
Pars Orbitalis 2.77 0.25 2.74 0.24 2.72 0.26 2.75 0.26  30.97 25.4 
 
0.29 0.21 
 
0.26 1.10 
 
0.44 0.04 
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Pars Triangularis 2.48 0.18 2.50 0.17 2.47 0.20 2.52 0.20 
 
36.51 30.99  0.00 0.81  0.15 0.10  0.03 0.36 
Pericalcarine 1.50 0.16 1.52 0.16 1.51 0.16 1.54 0.14 
 
36.04 34.35  0.33 0.09  0.00 0.00  1.38* 0.63 
Postcentral 2.03 0.12 2.02 0.13 2.04 0.13 2.00 0.12  18.53 13.86 
 
0.07 0.94 
 
0.14 0.01 
 
0.38 0.73 
Posterior Cingulate 2.52 0.18 2.49 0.17 2.52 0.19 2.49 0.16 
 
27.30 23.20  0.01 0.03  0.17 0.12  0.38 0.43 
Precentral 2.51 0.15 2.48 0.14 2.50 0.15 2.49 0.14 
 
32.00 24.94  0.38 0.02  0.65 0.03  0.15 1.01 
Precuneus 2.34 0.15 2.36 0.15 2.34 0.14 2.36 0.14  23.26 23.44 
 
0.00 0.08 
 
0.15 0.00 
 
0.37 0.84 
Rostral Anterior Cingulate 2.83 0.22 2.81 0.22 2.89 0.25 2.85 0.28 
 
13.69 17.31 
 
1.02 0.45 
 
0.16 1.47 
 
2.14* 0.45 
Rostral Middle Frontal 2.38 0.17 2.37 0.16 2.38 0.16 2.36 0.17 
 
34.76 35.68 
 
0.06 0.07 
 
0.40 0.24 
 
0.20 0.27 
Superior Frontal 2.73 0.16 2.72 0.16 2.71 0.16 2.71 0.18 
 
36.92 37.9 
 
0.21 0.00 
 
0.01 0.46 
 
0.31 0.20 
Superior Parietal 2.14 0.13 2.14 0.14 2.14 0.12 2.15 0.12 
 
16.1 12.91 
 
0.06 0.01 
 
0.20 0.16 
 
0.53 0.08 
Superior Temporal 2.79 0.16 2.82 0.18 2.79 0.18 2.83 0.16 
 
26.9 36.09 
 
0.00 0.02 
 
0.89 0.01 
 
1.46* 0.21 
Supramarginal 2.55 0.14 2.56 0.15 2.57 0.15 2.56 0.14 
 
24.61 19.55 
 
0.29 0.00 
 
0.09 0.01 
 
0.77 0.11 
Temporal Pole 3.68 0.32 3.78 0.33 3.64 0.31 3.73 0.31 
 
4.92 2.60 
 
0.34 0.46 
 
0.01 0.01 
 
1.29 0.39 
Transverse Temporal 2.31 0.23 2.35 0.24 2.28 0.21 2.33 0.25 
 
15.46 14.92 
 
0.87 0.33 
 
0.17 0.35 
 
2.07* 1.74* 
 
         
  
   
    
  
Mean 2.54 0.19 2.55 0.19 2.54 0.19 2.55 0.19 
 
22.95 22.70 
 
0.23 0.24 
 
0.21 0.20 
 
0.75 0.62 
 
Model 1 presents Total R squared for a model including age, age
2
 gender, education, and recording site.  Model 2 presents the delta R-squared 
when adding a group term (MDD+ vs MDD-).  Model 3a and 3b present the increment in r
2 
from the interaction term.  * = p < .05, ** = p < .01. 
Cortical thickness is expressed in millimeters. 
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Table 4. Effect of Depression on Cortical Thickness derived from DS Atlas 
 MDD+  MDD-  Model 1: 
 Covariates 
only  
 Model 2 
Adds MDD 
 Model 3a 
Adds Age x 
MDD 
 Model 3b 
Adds Gender x 
MDD 
 L R  L R  L R  L R  L R  L R 
 Mean SD Mean SD  Mean SD Mean SD  r
2 
%  ∆ r
2
 %  ∆ r
2
 %  ∆ r
2
 % 
Ins lg S cent ins  3.20 0.25 3.36 0.29  3.22 0.29 3.31 0.34  11.16 17.70  0.28 0.19  0.03 0.61  0.53 0.19 
S Cingul Ant  2.64 0.18 2.61 0.24  2.63 0.20 2.61 0.21  19.34 31.51  0.10 0.14  0.02 0.47  0.44 1.22 
S Cingul MidAnt  2.65 0.20 2.70 0.20  2.62 0.21 2.68 0.20  26.58 30.11  0.13 0.15  0.05 0.12  0.24 0.37 
S Cingul MidPost  2.53 0.18 2.54 0.17  2.51 0.17 2.55 0.17  34.71 36.12  0.01 0.36  0.21 0.07  0.03 0.34 
S frontomargin  2.35 0.21 2.38 0.23  2.36 0.24 2.40 0.24  21.53 22.15  0.00 0.01  0.18 0.17  0.07 0.58 
S Occipital Inf  2.41 0.23 2.56 0.19  2.40 0.20 2.55 0.24  6.41 6.88  0.02 0.00  0.02 0.65  0.66 0.14 
S Paracentral  2.26 0.18 2.20 0.19  2.22 0.18 2.19 0.19  20.02 25.52  0.05 0.22  0.12 0.40  0.01 0.01 
S Subcentral  2.68 0.19 2.72 0.19  2.70 0.18 2.68 0.18  25.40 19.37  0.19 0.71  0.25 0.05  0.19 0.06 
S Transv Fronto pol  2.59 0.31 2.55 0.24  2.60 0.22 2.56 0.23  17.60 21.73  0.01 0.00  0.03 0.14  1.09 0.00 
Cingul Postdorsal  2.94 0.22 2.89 0.18  2.90 0.21 2.91 0.19  25.07 19.43  0.16 0.51  0.80 0.31  1.88* 1.79* 
Cingul Postventral  2.38 0.30 2.71 0.31  2.44 0.31 2.70 0.30  8.69 15.85  0.82 0.01  0.02 0.07  0.01 2.19* 
 Cuneus  1.71 0.14 1.74 0.14  1.69 0.14 1.71 0.15  24.11 32.74  0.02 0.01  0.37 0.03  1.68* 1.82* 
Front Inf Opercular  2.77 0.18 2.79 0.21  2.76 0.18 2.77 0.19  31.47 26.59  0.05 0.13  0.32 0.38  0.24 1.24 
Front Inf Orbital  2.76 0.24 2.83 0.24  2.79 0.26 2.77 0.25  11.88 18.56  0.38 0.90  0.04 0.82  0.09 0.10 
Front Inf Triangul  2.64 0.22 2.71 0.22  2.67 0.20 2.68 0.20  32.99 22.28  0.08 1.21  0.16 0.10  0.00 0.23 
Front Middle  2.63 0.18 2.62 0.19  2.63 0.18 2.64 0.17  34.63 33.64  0.06 0.02  0.01 0.34  0.35 1.06 
Front Sup  2.84 0.17 2.83 0.18  2.85 0.18 2.84 0.17  36.76 35.43  0.13 0.05  0.01 0.30  0.64 0.21 
Insular Short  3.58 0.22 3.58 0.25  3.60 0.23 3.52 0.22  9.41 14.85  0.52 0.22  0.03 0.01  1.17 1.26 
Octemp Lat Fusifor  2.82 0.22 2.83 0.21  2.80 0.20 2.78 0.23  23.99 24.15  0.04 0.24  0.40 0.63  0.01 0.08 
Octemp Med Lingual  1.93 0.16 2.04 0.13  1.91 0.17 2.00 0.18  30.73 32.05  0.00 0.21  0.08 0.08  0.95 2.39** 
Octemp Med Parahip  3.06 0.27 3.08 0.27  3.10 0.29 3.09 0.30  15.00 16.84  0.84 0.26  0.11 0.15  0.89 0.00 
Occipital Middle  2.52 0.18 2.57 0.16  2.52 0.17 2.58 0.17  6.20 7.77  0.03 0.07  3.24** 0.00  0.00 1.38 
Occipital Sup  2.06 0.18 2.14 0.17  2.05 0.20 2.14 0.20  8.68 6.66  0.01 0.01  0.00 0.02  1.43 0.06 
Orbital  2.80 0.20 2.82 0.24  2.80 0.20 2.80 0.20  35.28 30.70  0.02 0.12  0.01 0.93  0.28 0.08 
Page 35 of 56
John Wiley & Sons, Inc.
Human Brain Mapping
57
58
59
60
This article is protected by copyright. All rights reserved.
Ac
c
e
p
t
e
d
 
A
r
t
i
c
l
e
Perlman 36 
 
Pariet Inf Angular  2.62 0.19 2.67 0.18  2.64 0.19 2.69 0.17  14.81 25.74  0.09 0.04  0.88 0.00  0.03 0.37 
Pariet Inf Supramar  2.72 0.17 2.72 0.17  2.72 0.16 2.73 0.18  20.57 22.15  0.04 0.01  0.29 0.59  0.54 0.00 
Parietal Sup  2.31 0.13 2.32 0.15  2.31 0.14 2.31 0.15  15.67 11.92  0.14 0.01  0.99 0.59  0.16 0.00 
Postcentral  2.13 0.17 2.06 0.17  2.11 0.16 2.11 0.17  13.44 10.11  0.01 2.03*  0.06 0.05  0.35 1.03 
Precentral  2.74 0.19 2.72 0.21  2.75 0.18 2.74 0.18  22.01 17.22  0.30 0.65  1.29 0.26  0.23 1.94* 
Precuneus  2.47 0.16 2.46 0.17  2.47 0.17 2.45 0.17  17.73 15.55  0.00 0.02  0.07 0.19  0.60 0.31 
Rectus  2.55 0.23 2.54 0.31  2.59 0.26 2.50 0.27  40.31 45.00  0.67 0.42  0.22 0.14  0.18 1.44* 
Subcallosal  2.68 0.48 2.55 0.42  2.61 0.39 2.49 0.41  8.87 11.05  0.38 0.15  0.37 0.00  0.01 0.00 
Temp sup G T Transv  2.36 0.20 2.41 0.27  2.37 0.23 2.41 0.26  11.71 13.88  0.16 0.05  0.09 0.29  1.79* 1.70* 
Temp Sup Lateral  3.07 0.19 3.10 0.21  3.08 0.20 3.09 0.20  17.13 28.51  0.11 0.00  0.16 0.19  1.03 0.34 
Temp Sup Plan polar  3.46 0.32 3.28 0.23  3.39 0.28 3.26 0.29  10.86 13.26  0.43 0.00  0.05 0.10  2.42* 0.03 
Temp Sup Plan tempo  2.56 0.21 2.57 0.19  2.57 0.19 2.58 0.20  10.03 16.55  0.04 0.04  0.65 0.03  3.15** 0.40 
Temporal Inf  2.96 0.20 3.00 0.20  2.94 0.21 2.94 0.22  21.09 21.02  0.00 0.79  0.32 0.02  0.25 0.08 
Temporal Middle  3.06 0.19 3.10 0.19  3.04 0.18 3.09 0.19  27.58 26.79  0.08 0.22  0.14 0.04  0.57 2.13* 
Lat Fis Ant Horizont  2.25 0.32 2.26 0.24  2.24 0.28 2.26 0.23  16.09 16.09  0.27 0.00  0.31 0.14  0.05 0.13 
Lat Fis Ant Vertical  2.42 0.28 2.48 0.34  2.37 0.28 2.45 0.31  20.99 17.02  0.49 0.16  0.06 0.00  0.11 0.22 
Lat Fispost  2.38 0.18 2.46 0.17  2.37 0.18 2.44 0.18  20.76 24.93  0.05 0.49  0.04 0.42  2.02* 0.17 
Pole Occipital  1.89 0.14 1.92 0.17  1.91 0.17 1.93 0.15  14.69 18.35  0.63 0.70  0.00 0.03  0.48 0.52 
Pole Temporal  3.31 0.21 3.35 0.23  3.38 0.25 3.39 0.25  8.75 7.35  1.99* 0.94  1.39 0.01  1.65* 0.12 
S calcarine  1.78 0.17 1.82 0.14  1.79 0.17 1.82 0.16  40.30 36.53  0.59 0.16  0.01 0.02  1.98** 1.09 
S central  1.80 0.17 1.78 0.15  1.81 0.15 1.77 0.16  31.20 27.13  0.74 0.10  1.54* 0.00  0.01 0.22 
S Cingul Marginalis  2.19 0.15 2.20 0.17  2.19 0.17 2.20 0.18  19.82 23.37  0.08 0.09  0.07 0.00  0.41 0.09 
S Circular Insula Ant  2.80 0.30 2.85 0.31  2.78 0.26 2.84 0.28  14.71 18.54  0.03 0.00  0.01 0.09  0.02 0.50 
S Circular Insula Inf  2.76 0.22 2.67 0.18  2.75 0.20 2.70 0.23  22.15 16.98  0.06 0.26  0.68 0.10  0.44 0.62 
S Circular Insula Sup  2.56 0.16 2.62 0.21  2.56 0.17 2.60 0.19  33.46 29.08  0.02 0.47  0.00 0.05  0.00 0.16 
S Collat Transv Ant  2.72 0.35 2.68 0.27  2.74 0.32 2.67 0.31  9.97 15.47  0.00 0.03  2.73* 0.37  0.82 0.05 
S Collat Transv Post  2.06 0.24 2.10 0.27  2.02 0.25 2.08 0.25  13.10 11.28  0.09 0.16  0.67 0.03  0.55 0.03 
S Front Inf  2.24 0.17 2.22 0.17  2.23 0.16 2.21 0.16  22.93 22.98  0.54 0.27  0.44 0.24  0.06 0.14 
S Front Middle  2.15 0.18 2.16 0.18  2.17 0.20 2.16 0.18  20.44 26.18  0.03 0.31  0.21 0.01  0.06 0.26 
S Front Sup  2.38 0.15 2.38 0.15  2.40 0.16 2.38 0.16  20.45 16.33  0.67 0.01  0.00 0.15  0.48 0.07 
S Interm Prim Jensen  2.52 0.43 2.24 0.18  2.38 0.35 2.28 0.20  5.48 8.95  2.62* 0.59  1.34 0.96  0.04 0.00 
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S Intrapariet P Trans  2.09 0.15 2.10 0.13  2.09 0.14 2.08 0.14  9.05 7.23  0.14 0.57  0.06 0.02  0.59 0.07 
S Octemp Lat  2.55 0.22 2.56 0.23  2.51 0.20 2.50 0.20  6.31 12.11  0.76 1.05  0.00 1.03  0.14 0.01 
S Octemp Med Lingual  2.40 0.20 2.37 0.18  2.39 0.20 2.35 0.22  31.71 26.58  0.00 0.01  0.00 0.02  0.03 0.33 
S OC Middle Lunatus  1.96 0.21 2.04 0.25  1.99 0.19 2.05 0.20  9.69 1.14  0.48 0.04  0.01 0.29  0.03 1.55 
S OC Sup Transversal  2.03 0.19 2.05 0.16  2.01 0.16 2.04 0.17  11.01 10.42  0.11 0.00  0.06 0.06  0.40 0.33 
S Occipital Ant  2.26 0.16 2.31 0.18  2.27 0.17 2.32 0.19  7.23 10.55  0.05 0.00  0.01 0.05  0.13 0.46 
S Orbital H Shaped  2.56 0.27 2.57 0.25  2.61 0.26 2.62 0.26  14.86 28.13  0.32 0.20  0.65 1.01  0.09 0.29 
S Orbital Lateral  2.17 0.36 2.16 0.32  2.19 0.32 2.21 0.30  19.62 23.83  0.17 0.03  0.03 0.02  0.23 0.80 
S Orbital Med olfact  2.37 0.29 2.23 0.32  2.40 0.33 2.20 0.29  16.18 19.84  0.09 0.57  0.26 0.03  0.00 0.00 
S Parieto Occipital  2.13 0.15 2.18 0.18  2.10 0.19 2.15 0.19  15.16 17.47  0.09 0.26  0.10 0.00  1.09 1.34 
S Pericallosal  2.31 0.33 2.19 0.28  2.30 0.34 2.18 0.26  11.27 15.24  0.02 0.16  0.55 0.00  0.07 0.13 
S Postcentral  2.08 0.13 2.01 0.14  2.06 0.14 2.02 0.15  18.41 11.13  0.28 0.22  0.07 0.00  0.86 0.75 
S Precentral Inf Part  2.41 0.16 2.44 0.15  2.43 0.18 2.42 0.17  31.73 21.71  0.14 0.38  0.51 0.96  0.64 0.04 
S Precentral Sup Part  2.32 0.15 2.34 0.19  2.34 0.19 2.33 0.21  21.86 28.85  0.26 0.01  0.00 0.17  0.02 0.28 
S Suborbital  2.30 0.28 2.40 0.43  2.40 0.31 2.41 0.43  12.55 7.37  1.78* 0.03  0.02 0.04  2.54* 0.26 
S Subparietal  2.30 0.20 2.35 0.21  2.34 0.19 2.40 0.19  16.72 22.21  1.06 1.78*  0.24 0.00  0.06 0.34 
S Temporal Inf  2.48 0.19 2.55 0.17  2.50 0.18 2.48 0.22  15.06 6.84  0.03 1.83*  0.17 0.49  0.24 0.25 
S Temporal Sup  2.45 0.15 2.50 0.15  2.44 0.14 2.48 0.14  29.28 30.38  0.27 0.26  0.00 0.24  0.82 0.19 
S Temporal Transverse  2.37 0.36 2.55 0.28  2.43 0.32 2.52 0.32  15.90 12.20  0.70 0.11  0.11 0.22  0.64 3.66** 
                       
Mean  2.49 0.21 2.50 0.22  2.49 0.22 2.51 0.21  19.17 19.96  0.30 0.30  0.33 0.22  0.57 0.57 
 
Model 1 presents Total R squared for a model including age, age
2
 gender, education, and recording site.  Model 2 presents the delta R-squared 
when adding a group term (MDD+ vs MDD-).  Model 3a and 3b present the increment in r
2 
from the interaction term.  * = p < .05, ** = p < .01. 
Cortical thickness is expressed in millimeters.
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Figure 1. Surface-Based Morphometry comparison of MDD+ to MDD- after multiple 
comparisons correction. Colorbar represents log(p), multiple comparisons corrected, where blue 
represents cortical thickening in MDD+ compared to MDD-. All maps thresholded at p < 0.05. 
Outlines of all DK regions are mapped onto the common atlas. 
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Supplemental Table 1. DK atlas and QIDS score 
 
 QIDS 
only 
 Model 1: 
 Covariates 
only  
 Model 2: 
Adds QIDS 
 Model 3a: 
Adds Age x 
QIDS 
 Model 3b: 
Adds Gender 
X QIDS 
  L R  L R  L R  L R  L R 
   r   r
2
 %  ∆ r
2
 %  ∆ r
2
 %  ∆ r
2
 % 
Bankssts  -0.13 -0.14  19.08 19.89  0.64 0.21  3.53** 0.17  0.03 0.23 
Caudal Anterior Cingulate  -0.15 -0.09  16.03 12.51  0.85 0.31  0.12 0.01  0.50 0.79 
Caudal Middle Frontal  -0.13 -0.13  23.51 24.26  1.54 1.65  0.33 1.87*  0.54 0.19 
Cuneus  -0.02 -0.08  21.50 31.40  0.03 0.41  0.76 0.01  0.01 0.07 
Entorhinal  0.12 0.12  14.05 21.62  0.38 0.37  0.31 0.19  0.54 0.00 
Frontal Pole  -0.04 0.09  19.42 10.60  0.03 0.74  0.20 3.53*  0.00 1.55 
Fusiform  -0.03 -0.01  26.29 24.46  0.19 0.01  0.50 0.12  1.06 0.40 
Inferior Parietal  -0.13 -0.11  15.44 20.90  1.11 0.79  0.62 0.08  0.00 0.14 
Inferior Temporal  0.02 -0.13  14.43 17.89  0.00 2.94*  0.01 0.01  0.09 0.02 
Insula  0.00 -0.05  19.01 27.95  0.06 0.07  0.00 0.09  0.44 0.00 
Isthmus Cingulate  -0.05 -0.04  17.45 14.34  0.15 0.15  0.90 0.00  0.12 0.06 
Lateral Occipital  -0.06 -0.10  11.88 10.28  0.55 0.58  0.23 0.19  0.38 0.16 
Lateral Orbitofrontal  0.01 -0.04  23.90 23.22  0.15 0.66  0.70 0.00  0.03 0.06 
Lingual  0.00 -0.01  37.98 35.62  0.01 0.04  0.56 0.57  2.08* 0.56 
Medial Orbitofrontal  -0.02 0.05  26.72 28.49  0.15 0.01  0.02 0.54  0.20 0.37 
Middle Temporal  -0.12 -0.22**  28.31 21.36  0.56 4.28**  1.23 0.01  0.01 0.06 
Paracentral  -0.07 -0.13  29.69 33.13  0.45 1.39  0.11 0.35  0.24 0.61 
Parahippocampal  0.02 0.02  10.34 18.53  0.01 0.00  0.58 0.07  2.96* 1.83 
Pars Opercularis  -0.10 -0.15  28.41 19.08  0.17 0.90  1.56 0.02  0.49 0.14 
Pars Orbitalis  -0.11 -0.04  27.08 17.64  1.33 0.04  1.50 0.29  1.07 0.26 
Pars Triangularis  -0.11 -0.08  29.92 26.69  0.56 0.06  0.18 0.04  0.13 0.09 
Pericalcarine  0.04 -0.02  38.73 35.87  0.41 0.07  0.63 1.91*  0.17 0.00 
Postcentral  -0.09 -0.08  18.05 17.07  0.55 0.84  0.26 0.02  0.00 0.11 
Posterior Cingulate  -0.04 -0.14  27.38 23.97  0.05 1.53  0.14 0.04  1.14 0.23 
Precentral  -0.18* -0.14  26.64 24.19  1.44 0.81  0.00 0.01  0.33 0.53 
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Precuneus  -0.16* -0.12  20.08 21.36  1.20 0.56  0.40 0.00  0.07 0.22 
Rostral Anterior Cingulate  -0.13 -0.04  15.15 12.14  1.12 0.01  0.07 0.00  0.00 0.40 
Rostral Middle Frontal  -0.11 -0.12  32.00 30.45  1.26 1.43  0.21 0.32  0.32 0.71 
Superior Frontal  -0.17* -0.15  32.81 29.75  1.98* 2.00*  1.28 1.03  0.03 0.67 
Superior Parietal  -0.16* -0.07  14.95 11.52  1.42 0.08  0.46 0.01  0.00 0.05 
Superior Temporal  -0.14 -0.11  20.20 29.99  0.65 0.26  0.13 0.21  0.06 0.20 
Supramarginal  -0.16* -0.07  21.38 16.79  1.48 0.35  0.19 0.13  0.08 0.08 
Temporal Pole  0.03 -0.06  6.77 2.63  0.26 0.50  0.40 1.78  0.49 0.08 
Transverse Temporal  -0.09 0.03  16.35 18.84  0.46 0.06  0.00 1.32  0.45 0.05 
                
Mean     22.09 21.60  0.62 0.71  0.53 0.44  0.41 0.32 
 
Model 1 presents Total R squared for a model including age, age
2
 gender, education, and imaging site.  Model 2 presents the delta R-squared 
when adding QIDS score.  Model 3a and 3b present the increment in r
2 
from the interaction term.  * = p < .05, ** = p < .01. Cortical thickness is 
expressed in millimeters.
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Supplemental Table 2. DS atlas and QIDS score 
  QIDS 
only 
 Model 1: 
 Covariates 
only  
 Model 2: 
Adds QIDS 
 Model 3a: 
Adds Age x 
QIDS 
 Model 3b: 
Adds Gender X 
QIDS 
  L R  L R  L R  L R  L R 
  r  r
2 
%  ∆ r
2
 %  ∆ r
2
 %  ∆ r
2
 % 
Ins lg S cent ins   -0.11 0.04  11.22 19.46  0.59 0.31  0.19 0.80  2.32* 0.52 
S Cingul Ant   -0.10 -0.05  16.31 25.92  1.20 0.19  0.55 0.35  0.90 1.04 
S Cingul MidAnt   -0.21** -0.10  29.12 25.69  3.13** 1.24  0.07 0.67  0.14 0.14 
S Cingul MidPost   -0.11 -0.13  33.87 35.89  0.41 0.83  0.30 0.03  0.31 0.21 
S frontomargin   -0.09 0.02  20.70 19.55  1.70 0.07  0.00 1.88  1.65 1.49 
S Occipital Inf   0.00 -0.07  7.80 10.82  0.01 0.57  0.27 0.05  0.00 0.06 
S Paracentral   -0.03 -0.06  23.00 24.78  0.14 0.28  0.18 0.03  0.02 0.21 
S Subcentral   -0.12 -0.11  20.78 16.31  0.50 0.30  0.20 0.95  0.10 0.48 
S Transv Fronto pol   -0.11 -0.09  18.36 16.92  1.05 0.99  0.04 0.32  0.84 1.75 
Cingul Postdorsal   -0.08 -0.04  22.70 20.35  0.28 0.00  0.19 0.51  0.54 0.00 
Cingul Postventral   -0.07 -0.04  10.10 20.70  0.61 0.55  0.08 0.01  0.00 0.23 
 Cuneus   0.01 -0.04  25.73 35.88  0.03 0.21  0.72 0.01  0.35 0.12 
Front Inf Opercular   -0.02 -0.14  27.59 21.82  0.09 1.14  2.48* 0.07  0.92 0.00 
Front Inf Orbital   -0.01 -0.09  10.88 13.33  0.00 0.80  0.48 2.62*  0.72 2.72* 
Front Inf Triangul   -0.16 -0.11  28.17 20.63  1.68 0.86  0.18 0.10  0.16 0.01 
Front Middle   -0.07 -0.13  31.57 27.80  0.60 1.32  0.05 0.56  0.15 0.09 
Front Sup   -0.16 -0.13  33.20 28.56  1.91* 1.54  1.35 1.19  0.01 0.24 
Insular Short   -0.02 -0.09  11.67 17.28  0.05 0.44  0.41 0.29  0.78 0.00 
Octemp Lat Fusifor   -0.06 -0.02  22.98 21.73  0.30 0.01  0.14 0.01  1.98* 1.03 
Octemp Med Lingual   0.01 0.02  32.66 35.68  0.05 0.05  0.47 0.26  1.87* 0.43 
Octemp Med Parahip   0.08 0.01  16.15 20.46  0.19 0.11  0.03 0.82  0.63 0.19 
Occipital Middle   -0.11 -0.12  4.35 8.02  1.76 0.85  0.09 0.87  0.34 0.10 
Occipital Sup   -0.12 -0.06  10.39 6.56  0.46 0.04  0.07 0.02  0.61 0.11 
Orbital   0.01 -0.02  37.07 28.55  0.28 0.47  0.54 0.01  0.19 0.01 
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Pariet Inf Angular   -0.11 -0.07  12.06 22.60  0.94 0.16  0.02 0.03  0.06 0.63 
Pariet Inf Supramar   -0.14 -0.03  15.92 18.54  1.67 0.24  0.25 0.04  0.11 0.00 
Parietal Sup   -0.19* -0.06  11.04 9.88  2.70* 0.18  0.15 0.03  0.20 0.00 
Postcentral   -0.10 -0.12  12.17 13.15  0.89 1.62  0.31 0.11  0.02 0.00 
Precentral   -0.15 -0.16*  16.21 14.21  0.67 1.13  0.03 0.61  0.53 0.30 
Precuneus   -0.17* -0.08  15.11 12.94  1.74 0.48  0.07 0.02  0.07 0.50 
Rectus   0.05 0.03  40.21 48.11  0.08 0.28  0.62 0.26  0.50 0.01 
Subcallosal   0.06 0.05  9.43 12.22  0.17 0.19  0.03 0.69  0.46 0.02 
Temp sup G T Transv   -0.08 0.05  12.07 17.85  0.69 0.14  0.01 1.61  0.06 0.12 
Temp Sup Lateral 
  
-0.10 -0.03 
 
13.11 21.72 
 
0.28 0.11 
 
0.34 0.10 
 
0.18 0.51 
Temp Sup Plan polar   -0.04 -0.09  13.56 12.74  0.00 0.40  0.14 0.03  0.02 0.03 
Temp Sup Plan tempo   -0.21** -0.08  8.03 15.81  2.39* 0.23  0.09 0.95  0.03 0.00 
Temporal Inf   -0.03 -0.10  17.98 23.74  0.28 2.49*  0.08 0.15  0.52 0.46 
Temporal Middle   -0.13 -0.17*  25.68 25.34  0.89 2.81*  1.91* 0.01  0.43 0.00 
Lat Fis Ant Horizont   0.01 -0.04  11.40 15.29  0.24 0.08  0.95 0.40  0.13 0.01 
Lat Fis Ant Vertical   -0.17* -0.02  19.19 11.87  1.01 0.24  0.68 0.02  0.00 0.21 
Lat Fispost   -0.17* -0.07  20.58 24.41  1.41 0.05  0.07 0.21  0.06 0.15 
Pole Occipital   -0.02 -0.03  12.50 17.34  0.33 0.01  0.52 2.87*  1.13 0.02 
Pole Temporal   0.01 -0.01  14.35 6.82  0.00 0.17  0.29 0.44  0.01 0.29 
S calcarine   0.00 -0.03  41.19 34.98  0.15 0.00  0.04 0.93  0.12 0.19 
S central   -0.05 -0.01  32.63 30.15  0.12 0.01  0.02 0.02  0.44 0.73 
S Cingul Marginalis   -0.09 -0.09  21.28 21.00  0.57 0.33  0.07 0.05  0.02 0.33 
S Circular Insula Ant   -0.06 -0.11  13.34 18.12  0.01 0.37  0.19 0.27  0.27 0.73 
S Circular Insula Inf   0.03 -0.01  17.74 18.29  0.68 0.05  0.05 0.00  0.27 0.88 
S Circular Insula Sup   -0.09 -0.12  27.27 23.71  0.28 0.48  0.17 0.05  0.00 0.04 
S Collat Transv Ant   0.15 -0.05  6.34 13.26  1.31 0.47  0.71 0.34  0.05 0.30 
S Collat Transv Post   -0.04 -0.15  17.52 9.12  0.00 1.43  0.69 0.02  2.77* 0.00 
S Front Inf   -0.16* -0.13  22.12 18.84  1.71 0.70  0.11 0.14  0.17 0.35 
S Front Middle   -0.01 -0.06  17.99 26.37  0.00 0.49  2.16* 0.02  0.81 0.18 
S Front Sup   -0.06 -0.15  18.86 15.11  0.22 2.20*  1.06 0.46  0.36 0.01 
S Interm Prim Jensen   -0.13 -0.01  9.29 10.18  0.85 0.23  0.01 0.00  0.11 0.00 
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S Intrapariet P Trans   -0.14 -0.09  11.06 7.10  0.86 0.38  0.25 0.00  0.01 0.00 
S Octemp Lat   -0.09 -0.02  6.84 18.79  0.27 0.00  0.31 0.41  0.01 0.17 
S Octemp Med Lingual   -0.03 -0.01  29.24 25.37  0.05 0.00  0.23 0.02  0.22 0.16 
S OC Middle Lunatus   0.00 -0.14  12.45 3.56  0.00 1.30  1.08 0.15  0.64 0.95 
S OC Sup Transversal   -0.08 -0.09  10.28 10.01  0.12 0.06  0.05 0.28  1.25 0.09 
S Occipital Ant   -0.05 -0.23**  6.44 10.70  0.36 5.29**  4.41** 0.11  0.08 0.03 
S Orbital H Shaped   -0.06 -0.04  9.45 23.55  0.40 0.19  2.35* 0.44  0.56 0.46 
S Orbital Lateral   -0.22** 0.09  15.94 15.66  3.98** 0.30  0.07 0.13  1.38 0.01 
S Orbital Med olfact   -0.05 0.02  16.45 22.32  1.01 0.13  0.00 0.21  0.01 0.09 
S Parieto Occipital   -0.11 -0.12  16.83 17.01  0.36 0.39  0.23 0.03  0.43 0.25 
S Pericallosal   -0.05 -0.09  13.82 13.83  0.00 0.57  0.21 0.03  1.04 0.11 
S Postcentral   -0.09 -0.02  19.86 13.06  0.37 0.04  2.16* 0.06  0.03 0.44 
S Precentral Inf Part   -0.19* -0.20*  33.00 23.12  2.06* 2.31*  0.11 1.39  0.37 0.01 
S Precentral Sup Part   -0.16* -0.11  20.74 26.63  2.34* 1.33  0.25 0.37  0.41 0.00 
S Suborbital   -0.12 -0.03  15.72 6.88  0.20 0.02  0.35 0.01  0.08 0.02 
S Subparietal   -0.09 -0.10  15.29 22.09  0.30 0.47  1.84 0.00  0.27 0.10 
S Temporal Inf   0.01 -0.18*  15.58 6.64  0.01 3.76**  0.00 0.23  0.95 0.18 
S Temporal Sup   -0.10 -0.18*  27.18 25.99  0.26 1.43  2.32* 0.06  0.03 0.00 
S Temporal Transverse   -0.18* -0.08  15.92 13.14  2.25* 0.40  0.39 0.66  0.03 0.15 
                 
Mean      18.44 19.08  0.74 0.67  0.51 0.38  0.45 0.29 
Model 1 presents Total R squared for a model including age, age
2
 gender, education, and imaging site.  Model 2 presents the delta R-squared 
when adding QIDS score.  Model 3a and 3b present the increment in r
2 
from the interaction term.  * = p < .05, ** = p < .01. Cortical thickness is 
expressed in millimeters.
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Supplemental Figure Legends 
 
Figure 1. Gender x Depression diagnosis interaction (p < 0.01) in the Left Cuneus defined by the 
Desikan-Killiany atlas. 
 
Figure 2. Gender x Depression diagnosis interaction (p < 0.01) in the Right Lingual defined by 
the Desikan-Killiany atlas. 
 
Figure 3. Age x Depression severity interaction (p < 0.01) in the Left Bankssts defined by the 
Desikan-Killiany atlas. 
 
Figure 4. Age x Depression diagnosis interaction (p < 0.01) in the Left G Occipital Middle 
defined by the Destrieux atlas. 
 
Figure 5. Gender x Depression diagnosis interaction (p < 0.01) in the Left Temp Sup Plan 
Tempo defined by the Destrieux atlas. 
 
Figure 6. Gender x Depression diagnosis interaction (p < 0.01) in the Left S Calcerine defined by 
the Destrieux atlas. 
 
Figure 7. Gender x Depression diagnosis interaction (p < 0.01) in the Right Octemp Med Lingual 
defined by the Destrieux atlas. 
 
Figure 8. Gender x Depression diagnosis interaction (p < 0.01) in the Right S Temporal 
Transverse defined by the Destrieux atlas. 
 
Figure 9. Age x Depression severity interaction (p < 0.01) in the Left S Occipital Ant defined by 
the Destrieux atlas. 
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